Literature DB >> 29530874

The authors respond to "The 2017 Canadian opioid guideline: already time for an overhaul".

Jason W Busse1, David Juurlink2, D Norman Buckley3, Gordon H Guyatt4.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 29530874      PMCID： PMC5849453          DOI： 10.1503/cmaj.68675

Source DB:  PubMed          Journal:  CMAJ        ISSN： 0820-3946            Impact factor:   8.262


× No keyword cloud information.
  3 in total

1.  Addressing the limitations of the CDC guideline for prescribing opioids for chronic noncancer pain.

Authors:  Jason W Busse; David Juurlink; Gordon H Guyatt
Journal:  CMAJ       Date:  2016-11-21       Impact factor: 8.262

2.  Response to "Clarification from the College of Physicians and Surgeons of BC on commentary about limitations of the CDC guideline for prescribing opioids".

Authors:  Jason W Busse; David Juurlink; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-04-03       Impact factor: 8.262

3.  Guideline for opioid therapy and chronic noncancer pain.

Authors:  Jason W Busse; Samantha Craigie; David N Juurlink; D Norman Buckley; Li Wang; Rachel J Couban; Thomas Agoritsas; Elie A Akl; Alonso Carrasco-Labra; Lynn Cooper; Chris Cull; Bruno R da Costa; Joseph W Frank; Gus Grant; Alfonso Iorio; Navindra Persaud; Sol Stern; Peter Tugwell; Per Olav Vandvik; Gordon H Guyatt
Journal:  CMAJ       Date:  2017-05-08       Impact factor: 8.262
  3 in total
  1 in total

1.  Addressing inaccurate claims about the Canadian opioid guideline.

Authors:  Jason W Busse; David Juurlink; D Norman Buckley; Gordon H Guyatt
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.